Literature DB >> 8180989

The sugar-combining area of the galactose-specific toxic lectin of mistletoe extends beyond the terminal sugar residue: comparison with a homologous toxic lectin, ricin.

R T Lee1, H J Gabius, Y C Lee.   

Abstract

Viscumin (the major lectin of mistletoe extract), also known as ML-1, and ricin (RCA II) belong to a group of heterodimeric toxic lectins composed of an A chain, which inhibits protein synthesis, and a B chain, which mediates entry into the cell in a galactose-specific manner. Although most of the binding force for the association of viscumin with galactose-containing ligands is generated by the nonreducing terminal galactose residue, a particular hydroxyl group on the penultimate sugar also appears to participate in the binding, suggesting that viscumin has an extended combining site. In this paper, we give further examples of affinity enhancement by the hydroxyl group situated on the penultimate sugar next to the glycosidic linkage of the terminal galactose. The structure with highest affinity for viscumin thus far discovered is beta-D-Gal-(1-->2)-beta-D-Gal. In contrast to viscumin, ricin does not have this extended binding area, as none of the disaccharides tested exhibited significant affinity enhancement.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180989     DOI: 10.1016/0008-6215(94)84259-0

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  9 in total

1.  Biological effects of natural and recombinant mistletoe lectin and an aqueous mistletoe extract on human monocytes and lymphocytes in vitro.

Authors:  U Elsässer-Beile; M Voss; R Schühle; U Wetterauer
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Ricin and viscumin bind to different sites of the cell membrane.

Authors:  M M Moisenovich; I A Demina; I I Agapov; O V Chelnokova; N V Kozlovskaya; J Bereiter-Hahn; A G Tonevitsky; V I Shumakov
Journal:  Dokl Biol Sci       Date:  2002 Mar-Apr

3.  Mistletoe lectin I in complex with galactose and lactose reveals distinct sugar-binding properties.

Authors:  Ruth Mikeska; Roland Wacker; Raghuvir Arni; Tej P Singh; Albert Mikhailov; Azat Gabdoulkhakov; Wolfgang Voelter; Christian Betzel
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2004-12-24

4.  Differences in Medium-Induced Conformational Plasticity Presumably Underlie Different Cytotoxic Activity of Ricin and Viscumin.

Authors:  Pavel Volynsky; Diana Maltseva; Valentin Tabakmakher; Eduard V Bocharov; Maria Raygorodskaya; Galina Zakharova; Elena Britikova; Alexander Tonevitsky; Roman Efremov
Journal:  Biomolecules       Date:  2022-02-11

5.  Dehydration of model membranes induced by lectins from Ricinus communis and Viscum album.

Authors:  P Pohl; S M Saparov; E E Pohl; V Y Evtodienko; I I Agapov; A G Tonevitsky
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

6.  Fine sugar specificity of the mistletoe (Viscum album) lectin I.

Authors:  H Debray; J Montreuil; H Franz
Journal:  Glycoconj J       Date:  1994-12       Impact factor: 2.916

Review 7.  [Protein-carbohydrate recognition. Foundation and medical application with illustrations of tumor lectin studies].

Authors:  H J Gabius; K Kayser; S Gabius
Journal:  Naturwissenschaften       Date:  1995-12

8.  Oncopharmacological Perspectives of a Plant Lectin (Viscum album Agglutinin-I): Overview of Recent Results from In vitro Experiments and In vivo Animal Models, and Their Possible Relevance for Clinical Applications.

Authors:  Tibor Hajtó; Katarina Hostanska; Timea Berki; László Pálinkás; Ferenc Boldizsár; Péter Németh
Journal:  Evid Based Complement Alternat Med       Date:  2005-01-28       Impact factor: 2.629

Review 9.  The immunomodulatory effect of plant lectins: a review with emphasis on ArtinM properties.

Authors:  Maria A Souza; Fernanda C Carvalho; Luciana P Ruas; Rafael Ricci-Azevedo; Maria Cristina Roque-Barreira
Journal:  Glycoconj J       Date:  2013-01-09       Impact factor: 2.916

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.